da Luca Bonadei | Giu 5, 2020 | Business
https://www.aboutpharma.com The landscape of startups expands with Empirica Therapeutics, created by a group of researchers from McMaster University and the University of Toronto, both in Canada. The researchers founded it on the encouraging results of a new Car-T...
da Luca Bonadei | Giu 5, 2020 | Clinical
http://www.lysogene.com Today Lysogene announced that, following discussions with the U.S. Food and Drug Administration (FDA), a clinical hold was issued for the clinical trial AAVance (NCT03612869), a global Phase 2/3 clinical trial of LYS-SAF302, a gene therapy for...
da Luca Bonadei | Giu 5, 2020 | Clinica
http://www.lysogene.com Lisogene ha annunciato oggi che, a seguito di discussioni con la Food and Drug Administration (FDA) degli Stati Uniti, è stata rilasciata una sospensione clinica per lo studio clinico AAVance (NCT03612869) di Fase 2/3 su LYS-SAF302, una terapia...
da Luca Bonadei | Feb 5, 2020 | Business
https://www.biospectrumasia.com GE Healthcare Life Sciences and Children’s Medical Research Institute will jointly drive the development of new affinity ligands for the purification of adeno-associated viral (AAV) vectors used in gene therapies. The focus of the...
da Luca Bonadei | Feb 5, 2020 | Business
https://www.biospectrumasia.com GE Healthcare Life Sciences e il Children’s Medical Research Institute (Australia) guideranno congiuntamente lo sviluppo di nuovi ligando con affinità per la purificazione dei vettori virali adeno-associati (AAV) utilizzati nelle...